CLRB - 1.21 Pre-market now at 1.57/1.69 Cellectar Announces Expansion of Relapsed/Refractory Multiple Myeloma Cohort in Phase 2 Trial of CLR 131 http://stockcharts.com/c-sc/sc?s=CLRB&p=D&b=5&g=0&i=t95152254838&r=1512565531933 http://stockcharts.com/c-sc/sc?s=CLRB&p=W&b=5&g=0&i=t52821288562&r=1512565550653